Finance

Beta
Lists
SIGHT:EPA
Gensight Biologics SA
€ ०.०८२
+०.२४%
(+०.०००२०) 1D
जुन १७, १४:४६:५० GMT+२  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for SIGHT...
Open
€ ०.०८
High
€ ०.०८
Low
€ ०.०८
Mkt. cap
१.९८ करोड
Avg. vol.
७.१४ लाख
Volume
७९.४२ हजार
52-wk high
€ ०.२४
52-wk low
€ ०.०८
EPS
-€ ०.०८
Shares outstanding
२३.५० करोड
No. of employees
१३
Open
€ ०.०८
High
€ ०.०८
Low
€ ०.०८
Mkt. cap
१.९८ करोड
Avg. vol.
७.१४ लाख
Volume
७९.४२ हजार
52-wk high
€ ०.२४
52-wk low
€ ०.०८
EPS
-€ ०.०८
Shares outstanding
२३.५० करोड
No. of employees
१३
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to SIGHT in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for SIGHT in the last 3 months.
Highest
Current € ०.०८
€ ०.४० (+३८६.६२%)
Average
€ ०.४० (+३८६.६२%)
Lowest
€ ०.४० (+३८६.६२%)
News stories
From sources across the web
Stock Titan
Stock Titan
·
६ मिनेट पहिले
Brand Engagement Network (NASDAQ: BNAI) plans $19.5M Cataneo acquisition
Foreign Policy Journal
Foreign Policy Journal
·
२३ मिनेट पहिले
Instacart (NASDAQ: CART) Leads All Rivals In Price Cuts As Grocery Delivery War Intensifies
PR Newswire UK
PR Newswire UK
·
१२ मिनेट पहिले
NYSE Content Update: Fed to Deliver First Rate Decision Under Chair Kevin Warsh
Yahoo Finance
Yahoo Finance
·
५७ मिनेट पहिले
Teradyne (TER) Joins The Nasdaq 100 As It Lands A $139.9 Million Air Force Deal
About Gensight Biologics SA
CEO-
Employees१३
Founded२०१२
Headquartersपेरिस, Île-de-France, फ्रान्स
Sector-
Last report
२०२६ जनवरी ८
Fiscal period
Q4 2025
EPS / Est. (EUR)
- / -
Revenue / Est. (EUR)
३.०२ लाख / -
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
२०२५ मार्च
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
Revenue
२४.०० हजार
२४.०० हजार
३.०२ लाख
३.०२ लाख
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
२१.४२ लाख
२१.४२ लाख
१०.७८ लाख
१०.७८ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१२.७६ लाख
१२.७६ लाख
१३.५६ लाख
१३.५६ लाख
Operating expense
३४.१९ लाख
३४.१९ लाख
२४.३४ लाख
२४.३४ लाख
Total operating expenses
३४.१९ लाख
३४.१९ लाख
२४.३४ लाख
२४.३४ लाख
Operating income
-३३.९५ लाख
-३३.९५ लाख
-२१.३२ लाख
-२१.३२ लाख
Other non operating income
६.९७ लाख
६.९७ लाख
४.३६ लाख
४.३६ लाख
EBT including unusual items
-३४.८८ लाख
-३४.८८ लाख
-२५.३२ लाख
-२५.३२ लाख
EBT excluding unusual items
-३४.८८ लाख
-३४.८८ लाख
-२५.३२ लाख
-२५.३२ लाख
Income tax expense
-४.५० हजार
-४.५० हजार
२.०० हजार
२.०० हजार
Effective tax rate
०.१३%
०.१३%
-०.०८%
-०.०८%
Other operating expenses
-
-
-
-
Net income
-३४.८४ लाख
-३४.८४ लाख
-२५.३४ लाख
-२५.३४ लाख
Net profit margin
-१४,५१४.५८%
-१४,५१४.५८%
-८३९.२४%
-८३९.२४%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-६.६० लाख
-६.६० लाख
-७.८४ लाख
-७.८४ लाख
Net interest expenses
-६.६० लाख
-६.६० लाख
-७.८४ लाख
-७.८४ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-३३.५५ लाख
-३३.५५ लाख
-२०.९३ लाख
-२०.९३ लाख
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more